# ODONATE THERAPEUTICS INC (ODTC)

> Institutional ownership reported to the SEC as of Q1 2022, from Form 13F filings. Source: https://holderbook.com/stocks/ODTC/

- Reporting holders: 6
- Reported value: $7.1M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [BOXER CAPITAL, LLC](https://holderbook.com/funds/1465837-boxer-capital-llc/) | $5.6M | 4,207,086 | 0.3% | 14 |
| [Samsara BioCapital, LLC](https://holderbook.com/funds/1744967-samsara-biocapital-llc/) | $925.0K | 700,421 | 0.2% | 14 |
| [ACADIAN ASSET MANAGEMENT LLC](https://holderbook.com/funds/916542-acadian-asset-management-llc/) | $506.0K | 384,995 | 0.0% | 5 |
| [Hennion & Walsh Asset Management, Inc.](https://holderbook.com/funds/1861642-hennion-walsh-asset-management-inc/) | $91.0K | 69,264 | 0.0% | 5 |
| [Tower Research Capital LLC (TRC)](https://holderbook.com/funds/1533421-tower-research-capital-llc-trc/) | $58.0K | 43,752 | 0.0% | 9 |
| [SIMPLEX TRADING, LLC](https://holderbook.com/funds/1488542-simplex-trading-llc/) | $2.0K | 2,000 | 0.0% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2022 | 6 | $7.1M |
| Q4 2021 | 45 | $32.8M |
| Q3 2021 | 56 | $95.1M |
| Q2 2021 | 64 | $115.7M |
| Q1 2021 | 76 | $112.9M |
| Q4 2020 | 93 | $745.7M |
| Q3 2020 | 88 | $501.9M |
| Q2 2020 | 95 | $1.3B |
| Q1 2020 | 78 | $850.0M |
| Q4 2019 | 87 | $1.0B |
| Q3 2019 | 81 | $821.9M |
| Q2 2019 | 77 | $1.1B |